Amgen Inc.
AMGN
$438.82-5.07 (1.14%)Nov 19
After-hours: $439.10 (+0.06%)
Amgen Inc. (AMGN)
$438.82-5.07-1.14%Nov 19
Loading chart…
USA›Health Care›Biotechnology›Biotechnology
YTD34%
M.cap.237.4 bn
Std.Dev, 1y1.59
Vol, bn1.1 (med)
RSI32
P/E19.5
MFI43
P/S6.13
ADX36 (trend)
P/B16.54
Beta0.44
Div$10.08 (2.30%)
Debt/EBITDA3.23
Payout45%
Price target
Buy 9 (36%)Hold 13 (52%)Sell 3 (12%)
Next earnings2 Feb, after close
Earnings surprise
Short interest2.3% (-0.1%), 30 Oct 2026
Fund owners #2,982 (-284)
Insider ownership$980 mm
Insider sellingVery Low
Insider buying—
General
M.Cap$237.4B
Dividends$10.08 (2.30%, )
Next report2 Feb, after close
Forecast
Valuation
Target
P/E19.5
P/S6.13
P/B16.54
Fundamentals
5-y avg sales growth+7.6%
Debt / EBITDA3.23
ROE89.1%
Altman Z-score1.69 (distress)
Technicals
RSI32
MFI43
Price / MA50+2.2% (med) ↓
Trend pattern
Financial Statements
No data available
Financial Statements
No data available
Team
Loading…
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Investor Presentations
Loading…
Options
Exp. from:to:
Strike from:to:
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
Stress Test
Loading…
About

Amgen Inc. is a global firm that develops, manufactures, and distributes human therapeutics for various ailments such as inflammation, oncology/hematology, and bone health. The company delivers high-quality products such as Enbrel, Neulasta, Prolia, and Xgeva, among others, to healthcare providers, including dialysis centers, hospitals, and pharmacies worldwide. Additionally, the firm has collaboration agreements with several leading players in the pharmaceutical industry, including Novartis, Eli Lilly and Company, and Bayer Healthcare LLC.

WikipediaHeadcount: 31,500
Website: www.amgen.com
Address:One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799
About

Amgen Inc. is a global firm that develops, manufactures, and distributes human therapeutics for various ailments such as inflammation, oncology/hematology, and bone health. The company delivers high-quality products such as Enbrel, Neulasta, Prolia, and Xgeva, among others, to healthcare providers, including dialysis centers, hospitals, and pharmacies worldwide. Additionally, the firm has collaboration agreements with several leading players in the pharmaceutical industry, including Novartis, Eli Lilly and Company, and Bayer Healthcare LLC.

https://www.amgen.com
Beta 0.44